Download PDF
Exp Clin Endocrinol Diabetes 2001; Vol. 109(1): 47-51
DOI: 10.1055/s-2001-11012
Mini-Review

© Johann Ambrosius Barth

Sodium/iodide symporter in thyroid cancer

C. Mian 1 , L. Lacroix 1 , J.-M. Bidart 1 , B. Caillou 2 , S. Filetti 4 , M. Schlumberger 3
  • 1 Departments of Clinical Biology, 2 Pathology and 3 Nuclear Medicine and Endocrine Tumors, Institut Gustave-Roussy, Villejuif, France
  • 4 Department of Endocrinology, Catanzaro, Italy
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Key words:

Iodide transport - Na+/I- symporter - thyroid tumors

References

  • 1 Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes.  J Clin Endocrinol Metab. 82 1638-1641 1997; 
    CrossrefPubMedGoogle Scholar
  • 2 Arturi F, Russo D, Schlumberger M, DuVillard J A, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez H G, Filetti S. Iodide symporter gene expression in human thyroid tumors.  J Clin Endocrinol Metab. 83 2493-2496 1998; 
    PubMedGoogle Scholar
  • 3 Arturi F, Russo D, Giuffrida D, Schlumberger M, Filetti S. Sodium-iodide symporter (NIS) gene expression in lymph node metastases of papillary thyroid carcinomas.  Eur J Endocrinol. (in press); 
    PubMedGoogle Scholar
  • 4 Avvedimento V E, Musti A M, Ueffing M, Obici S, Gallo A, Sanchez M, DeBrasi D, Gottesman M E. Reversible inhibition of thyroid-specific trans-acting factor by Ras.  Genes Development. 5 22-28 1991; 
    PubMedGoogle Scholar
  • 5 Bidart J M, Mian C, Lazar V, Mahe C, Filetti S, Caillou B, Schlumberger M. Expression of Pendrin and Pendred syndrome (PDS) gene in human thyroid tissues.  J Clin Endocrinol Metab. 85 2028-2033 2000; 
    CrossrefPubMedGoogle Scholar
  • 6 Caillou B, Troalen F, Baudin E, Talbot M, Filetti S, Schlumberger M, Bidart J. Immunohistochemical detection of the Na+/I- symporter in human thyroid tissues.  J Clin Endocrinol Metab. 83 4102-4106 1998; 
    CrossrefPubMedGoogle Scholar
  • 7 Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter.  Nature. 379 458-460 1996; 
    CrossrefPubMedGoogle Scholar
  • 8 De Vita G, Zannini M, Cirafici A M, Melillo R M, Di Lauro R, Fusco A, Santoro M. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors.  Cell Growth & Differentiation. 9 97-103 1998; 
    PubMedGoogle Scholar
  • 9 Feine U, Lietzenmayer R, Hanke J P, Held J, Wohrle H, Muller-Schauenburg W. Fluorine-18-FDG and iodine 131 uptake in thyroid cancer.  J Nucl Med. 37 1468-1472 1996; 
    PubMedGoogle Scholar
  • 10 Filetti S, Bidart J M, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.  Eur J Endocrinol. 141 443-457 1999; 
    CrossrefPubMedGoogle Scholar
  • 11 Fragu P, Nataf B M. Thyroid peroxidase activity in benign and malignant thyroid disorders.  J Clin Endocrinol Metab. 45 1089-1093 1977; 
    PubMedGoogle Scholar
  • 12 Francis-Lang H, Zannini M S, De Felice M, Berlingieri M T, Fusco A, Di Lauro R. Multiple mechanisms of interference between transformation and differentiation in thyroid cells.  Mol Cell Biol. 12 5793-5800 1992; 
    PubMedGoogle Scholar
  • 13 Fusco A, Berlingieri M T, Di Fiore P P, Portella G, Grieco M, Vecchio G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes.  Mol Cell Biol. 7 3365-3370 1987; 
    PubMedGoogle Scholar
  • 14 Goldman J M, Line B R, Aamodt R L, Robbins J. Influences of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer.  J Clin Endocrinol Metab. 50 734-739 1980; 
    PubMedGoogle Scholar
  • 15 Haugen B R, Pacini F, Reiners C, Schlumberger M. et al . A comparison of Recombinant Human Thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.  J Clin Endocrinol Metab. 84 3877-3885 1999; 
    CrossrefPubMedGoogle Scholar
  • 16 Jhiang S M, Cho J-Y, Ryu K-Y, DeYoung B R, Smanik P A, McGaughy V R, Fischer A H, Mazzaferri E L. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.  Endocrinology. 139 4416-4419 1998; 
    CrossrefPubMedGoogle Scholar
  • 17 Jhiang S M, Sagartz J E, Tong Q, Parker-Thornburg J, Capen C C, Cho J Y, Xing S, Ledent C. Targeted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas.  Endocrinology. 137 375-378 1996; 
    CrossrefPubMedGoogle Scholar
  • 18 Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T. Regulation by Thyroid-Stimulating Hormone of Sodium/Iodide symporter gene expression and protein levels in FRTL-5 cells.  Endocrinology. 138 2227-2232 1997; 
    CrossrefPubMedGoogle Scholar
  • 19 Koong S S, Reynolds J C, Movius E G, Keenan A M, Ain K B, Lakshmanan M C, Robbins J. Lithium as a potent adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.  J Clin Endocrinol Metab. 84 912-916 1999; 
    CrossrefPubMedGoogle Scholar
  • 20 Lazar V, Bidart J M, Caillou B, Mahé C, Lacroix L, Filetti S, Schlumberger M. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.  J Clin Endocrinol Metab. 84 3228-3234 1999; 
    PubMedGoogle Scholar
  • 21 Maxon H R, Thomas S R, Hertzberg V S, Kereiakes J G, Chen I W, Sperling M L, Saenger E L. Relation between effective radiation dose and outcome of radioiodide therapy for thyroid cancer.  N Engl J Med. 309 937-941 1983; 
    CrossrefPubMedGoogle Scholar
  • 22 Maxon H R, Smith H S. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.  Endocrinol Metab Clin N Am. 19 685-718 1990; 
    PubMedGoogle Scholar
  • 23 Missero C, Cobellis G, De Felice M, Di Lauro R. Molecular events involved in differentiation of thyroid follicular cells.  Mol Cell Endocrinol. 140 37-43 1998; 
    CrossrefPubMedGoogle Scholar
  • 24 Rochefort P, Caillou B, Michiels F M, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.  Oncogene. 12 111-118 1996; 
    PubMedGoogle Scholar
  • 25 Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.  J Clin Endocrinol Metab. 82 3331-3336 1997; 
    CrossrefPubMedGoogle Scholar
  • 26 Santoro M, Melillo R M, Grieco M, Berlingieri M T, Vecchio G, Fusco A. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat epithelial cell line.  Cell Growth Differentiation. 4 77-84 1993; 
    PubMedGoogle Scholar
  • 27 Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.  Oncogene. 12 1821-1826 1996; 
    PubMedGoogle Scholar
  • 28 Schlumberger M, Charbord P, Fragu P, Gardet P, Lumbroso J, Parmentier C. et al . Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma.  J Clin Endocrinol Metab. 57 148-151 1983; 
    PubMedGoogle Scholar
  • 29 Schlumberger M, Challeton C, De Vathaire F, Travagli J P, Gardet P, Lumbroso J D, Francese C, Fontaine F, Richard M, Parmentier C. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.  J Nucl Med. 37 598-605 1996; 
    PubMedGoogle Scholar
  • 30 Schlumberger M. Papillary and follicular thyroid carcinoma.  N Engl J Med. 338 297-306 1998; 
    CrossrefPubMedGoogle Scholar
  • 31 Schlumberger M, Baudin E. Serum Thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.  Eur J Endocrinol. 138 249-252 1998; 
    CrossrefPubMedGoogle Scholar
  • 32 Smanik P A, Liu Q, Furminger T L, Ryu K-Y, Xing S, Mazzaferri E L, Jhiang S M. Cloning of the human sodium iodide symporter.  Biochemical and Biophysical Research Communication. 226 339-345 1996; 
    CrossrefPubMedGoogle Scholar
  • 33 Smanik P A, Ryu K Y, Theil K S, Mazzaferri E L, Jhiang S M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.  Endocrinology. 138 3555-3558 1997; 
    CrossrefPubMedGoogle Scholar
  • 34 Suarez H G. Genetic alterations in human epithelial tumors.  Clin Endocrinol. 48 531-546 1998; 
    CrossrefPubMedGoogle Scholar
  • 35 Thomas-Morvan C, Nataf B, Tubiana M. Thyroid proteins and hormone synthesis in human thyroid cancer.  Acta Endocrinol (Copenh). 76 651-669 1974; 
    PubMedGoogle Scholar
  • 36 Thomas-Morvan C, Carayon P, Schlumberger M, Vignal A, Tubiana M. Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer.  Acta Endocrinol (Copenh). 101 25-31 1982; 
    PubMedGoogle Scholar
  • 37 Valenta L J. Thyroid peroxidase, thyroglobulin, cAMP and DNA in human thyroid.  J Clin Endocrinol Metab. 43 466-469 1976; 
    PubMedGoogle Scholar
  • 38 Trapasso F, Iuliano R, Chiefari E, Arturi F, Stella A, Filetti S, Fusco A, Russo D. Iodide symporter gene expression in normal and transformed rat thyroid cells.  Eur J Endocrinol. 140 447-451 1999; 
    CrossrefPubMedGoogle Scholar
  • 39 Wang W, Larson S M, Fazzari M. et al . Prognostic value of (18F) Fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.  J Clin Endocrinol Metab. 85 1107-1113 2000; 
    CrossrefPubMedGoogle Scholar
  • 40 Wartofsky L, Sherman S I, Gopal J, Schlumberger M, Hay I D. Therapeutic Controversy. The use of radioactive iodine in patients with papillary and follicular thyroid cancer.  J Clin Endocrinol Metab. 83 4195-4203 1998; 
    CrossrefPubMedGoogle Scholar
  • 41 Wynford-Thomas D. Molecular genetics of thyroid cancer.  Trends in Endocrinology and Metabolism. 4 224-232 1993; 
    CrossrefPubMedGoogle Scholar

Martin Schlumberger

Department of Nuclear Medicine and Endocrine Tumors

Institut Gustave-Roussy

F-94805 Villejuif

France

Phone: +33-1-42-11-4496

Fax: +33-1-42-11-5223

Email: schlumbg@igr.fr